Health & Wellness American Lung Association urges high-risk individuals to get lung cancer screening Only 16.0 per cent of eligible individuals underwent lung cancer screening in 2022 Joseph MortonNovember 20, 2024
Health & Wellness Breath Diagnostics onboards new president and closes critical financing Aaron Roebuck brings three decades of experience in respiratory and cardiopulmonary medicine, and commercialization of medical devices Joseph MortonOctober 31, 2024
Medical and Pharmaceutical New Brunswick to use blood testing method for identifying lung cancer This will be the first time that labs in Atlantic Canada utilize liquid biopsies to test for the disease Rowan DunneSeptember 16, 2024
Medical and Pharmaceutical University of Notre Dame develops novel blood testing method for brain cancer Although considered incurable, they hope early detection of glioblastoma may increase a person's survival chances Rowan DunneAugust 27, 2024
Medical and Pharmaceutical Breath Diagnostics pioneers novel lung cancer breath test Development of a 'MicroReactor' has given the company a superior advantage over other breath analysis tech Rowan DunneAugust 23, 2024